FDAnews
www.fdanews.com/articles/136886-vyvanse-magnet-attracts-ddmac-warning

Vyvanse Magnet Attracts DDMAC Warning

May 18, 2011
The FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC) recently warned Shire Pharmaceuticals for a “violative” promotional magnet for its attention deficit hyperactivity disorder (ADHD) drug Vyvanse. The magnet, which DDMAC learned of through its Truthful Prescription Drug Advertising and Promotion, or Bad Ad, program, “makes representations regarding the use of Vyvanse, but omits the full indication and risks associated with the use of the drug,” DDMAC says.
Drug Industry Daily